We congratulate FLS on their 30th anniversary and thank them for their invaluable assistance in helping AELIX Therapeutics to advance the HIV cure research agenda through the excellent clinical trials support provided by FLS for our #HTI vaccine studies. ow.ly/1XWC50JaZps

AELIX Therapeutics has made a donation to Fundación ”la Caixa” ’s project Alliance for Child Vaccination to contribute to the fight to reduce premature deaths of children in the world’s most vulnerable areas and to give them hope for a better future. #VacunaciónlaCaixa Fundación ”la Caixa”

Meet us at World Vaccine Conference #WVCEU where AELIX Therapeutics will be presenting this year. Excited to be participating together with other world class vaccine researchers and to provide an update on AELIX´s cutting edge research on the development of vaccines for #HIV cure.

Positive results from AELIX Therapeutics' #HIV #therapeutic #vaccine #clinicalstudy AELIX-002 have been published in Nature Medicine: ow.ly/kEak50Lrau6”

Exclusive #VaccineNation interview with AELIX Therapeutics’s CSO, Dr. Christian Brander, on the development of #HIV #therapies. ow.ly/Jk8Y50LH2QI

On #WorldAIDSday, AELIX Therapeutics wishes to thank all our #research teams, #funders and study participants, for their invaluable contribution in our quest of finding a functional cure for #HIV infection to help achieve physical, mental and social wellbeing of all people living with HIV

💉¿Está más cerca la vacuna contra el VIH? Los investigadores de IrsiCaixa Christian Brander y Beatriz Mothe nos explican los resultados del ensayo clínico de la vacuna HTI de AELIX Therapeutics. ¡Descúbrelo aquí! ⬇️ epe.es/es/salud/20221…

💉 ¿Será posible tratar el VIH con una vacuna? El investigador #CaixaResearch Christian Brander, de AELIX Therapeutics y IrsiCaixa, desarrolla una vacuna terapéutica de células T que permite controlar el virus sin tratamiento antirretroviral. diariomedico.com/medicina/enfer…

#article IrsiCaixa and AELIX Therapeutics explain in Biotech-Spain.com article what is needed to develop a #therapeutic #HIV #vaccine ow.ly/z4yT50MJ798

We are excited to announce that the lead investigator, BeaMothe and our CSO, Christian Brander, will present the topline results from our clinical trial AELIX-003 at the CROI conference. The data will be presented in a late-breaker session on Feb 21st. ow.ly/lIyx50MSUmq

AELIX has presented promising top-line results from the #clinical #study AELIX-003 at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI). #HIV #Innovation #Immunotherapy #therapeuticvaccine ➡️ ow.ly/LnJ550MYssf

Christian Brander explains the AELIX Therapeutics #HIV #therapeutic #vaccine in the recent interview for elEconomista.es ➡️ ow.ly/EifW50N9wpp

Small team running a big project! We are proud to be a part of the AELIX Therapeutics success story that we hope will pave a path for an effective #therapeutic #vaccine against #HIV #infection.

Jordi Naval and Christian Brander explain the AELIX Therapeutics ’ HIV #therapeutic #vaccine and the results of the AELIX Therapeutics #clinical #trials in the interview for CincoDiascom ⬇️ Click⬇️ buff.ly/40TtgM9

AELIX Therapeutics keeps supporting Fundación ”la Caixa”’s project Alliance for Child Vaccination to contribute to the fight to reduce premature deaths of children in the world’s most vulnerable areas and to give them hope for a better future. #VacunaciónlaCaixa Fundación ”la Caixa”

AELIX is proud to support the #LGTBIQ+ community and work towards a better world without prejudice. #pride #lgtbiq <a href="buff.ly/3PvXSAB">Image by Vectonauta</a> on Freepik

AELIX is proud to be shortlisted by LabiotechGroup as one of the five #Spanish #biotech #companies one should know about: Five biotech companies you should know about in Spain (buff.ly/2UE17Hk)

Christian Brander and Thomas Hecht from the AELIX Therapeutics team are attending the upcoming World Vaccine Conference #WVCEU in #Barcelona. We will be happy to meet you there and to discuss our latest research progress and #clinical data on development of #vaccines for #HIV cure.

AELIX Therapeutics is attending the Jeffries Healthcare Conference in London on 14-16 Nov. Thomas Hecht, our Executive Chairman and Karen Wagner, YsiosCapital and Aelix BoD member, will be happy to meet you and discuss our latest research progress in development of #vaccines for #HIV cure

On #WorldAIDSday, AELIX Therapeutics acknowledges the progress towards a cure for HIV infection. This is not possible without the continued engagement of study participants, funders, and the research teams. The goal remains, the journey continues, and we thank you for your participation